Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Rang in Aktien #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Aktienkurs
$0.01317984
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$10.52M
Veränderung (1 Tag)
-1.26%
Veränderung (1 Jahr)
-53.51%
Land
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Kategorie

Kursverlauf für Spago Nanomedical AB (publ) (SPAGO)
Höchster Schlusskurs: $0.01 am 2026-08-01

Niedrigster Schlusskurs: $1.82 am 2013-01-01
Kursverlauf der Aktie von Spago Nanomedical AB (publ) von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 49.55%
2025 -31.97%
2024 -41.92%
2023 -54.33%
2022 -87.66%
2021 -49.08%
2020 -37.41%
2019 30.59%
2018 14.03%
2017 -24.70%
2016 -12.65%
2015 29.84%
2014 -30.41%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$110.17 -37.47%
AU
$736.64 6.99%
CH
$1.06K -6.61%
KR